Alkermes plc. Marketable Securities (Non-Current)
Alkermes plc. (ALKS) had Marketable Securities (Non-Current) of $137.47 million as of 2018-03-31, per its 10-Q filed 2018-04-26.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:MarketableSecuritiesNoncurrent · last filed 2018-04-26
- 2018-03-31: Marketable Securities, Noncurrent $137.47M.
- 2017-12-31: Marketable Securities, Noncurrent $157.21M.
- 2017-09-30: Marketable Securities, Noncurrent $118.75M.
- 2017-06-30: Marketable Securities, Noncurrent $85.72M.
| Period end | Marketable Securities, Noncurrent |
|---|---|
| 2018-03-31 | $137.47M 10-Q · filed 2018-04-26 |
| 2017-12-31 | $157.21M 10-Q · filed 2018-04-26 |
| 2017-09-30 | $118.75M 10-Q · filed 2017-10-26 |
| 2017-06-30 | $85.72M 10-Q · filed 2017-07-27 |
| 2017-03-31 | $112.95M 10-Q · filed 2017-04-27 |
| 2016-12-31 | $121.93M 10-K · filed 2018-02-16 |
| 2016-09-30 | $75.15M 10-Q · filed 2016-11-02 |
| 2016-06-30 | $21.69M 10-Q · filed 2016-07-28 |
| 2016-03-31 | $93.99M 10-Q · filed 2016-04-28 |
| 2015-12-31 | $264.07M 10-K · filed 2017-02-17 |
| 2015-09-30 | $43.74M 10-Q · filed 2015-10-29 |
| 2015-06-30 | $55.59M 10-Q · filed 2015-07-30 |
| 2015-03-31 | $58.25M 10-Q · filed 2015-04-30 |
| 2014-12-31 | $170.48M 10-K · filed 2016-02-25 |
| 2014-09-30 | $143.75M 10-Q · filed 2014-10-29 |
| 2014-06-30 | $75.41M 10-Q · filed 2014-07-31 |
| 2014-03-31 | $149.49M 10-Q · filed 2014-04-30 |
| 2013-12-31 | $87.76M 10-K · filed 2015-02-24 |
| 2013-09-30 | $55.81M 10-Q · filed 2013-10-31 |
| 2013-06-30 | $96.45M 10-Q · filed 2013-07-25 |
| 2013-03-31 | $82.83M 10-KT · filed 2014-02-27 |
| 2012-12-31 | $29.98M 10-Q · filed 2013-01-31 |
| 2012-09-30 | $8.73M 10-Q · filed 2012-11-01 |
| 2012-06-30 | $67.56M 10-Q · filed 2012-07-26 |
| 2012-03-31 | $55.69M 10-K · filed 2013-05-23 |
| 2011-12-31 | $20.52M 10-Q · filed 2012-02-02 |
| 2011-09-30 | $24.99M 10-Q · filed 2011-11-03 |
| 2011-03-31 | $93.41M 10-K · filed 2012-05-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |